LY-255582

From WikiMD's Food, Medicine & Wellness Encyclopedia

LY-255582 is a drug that is used in scientific research. It is a non-selective opioid antagonist that has been shown to reduce alcohol intake in animal studies. LY-255582 has also been found to have anti-obesity effects in rats, possibly due to its ability to reduce food intake and increase energy expenditure.

Pharmacology[edit | edit source]

LY-255582 is a non-selective opioid antagonist, meaning it blocks the effects of opioids in the body. This is achieved by binding to opioid receptors in the brain and preventing opioids from exerting their effects. The exact mechanism by which LY-255582 reduces alcohol intake and has anti-obesity effects is not fully understood, but it is thought to involve a reduction in the rewarding effects of food and alcohol.

Uses[edit | edit source]

LY-255582 has been used in scientific research to study the effects of opioids on alcohol intake and obesity. In animal studies, it has been shown to reduce alcohol intake and have anti-obesity effects. However, it is not currently used in clinical practice.

Side Effects[edit | edit source]

As with all drugs, LY-255582 can have side effects. These can include nausea, vomiting, and abdominal pain. However, these side effects are generally mild and go away on their own.

See Also[edit | edit source]

LY-255582 Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD